GlaxoSmithKline's potential proxy brawl with activist Elliott has U.K. officials worried: report

GlaxoSmithKline's fate has looked uncertain ever since aggressive activist investor Elliott Management took a major stake in the U.K.-based pharma last month. Now, after winning the support of several prominent investors, GSK has the British government watching its back.